Phone: (414) 918-9822    Email: [email protected]

Grants and Funding

CARRA offers members various funding and internship opportunities to further research that leverages the CARRA network and positively impacts the pediatric rheumatology scientific community and advances the CARRA mission. Additional information for the different grant opportunities, including the application instructions and templates are available below.


Important Deadlines

Click here to view a pdf document of everything you will asked to provide in the online grant application form.  This is provided as a guide. Individual uploadable templates are provided below.

CARRA Grant Applications to Include

  • LOI (for large grants only, due September 1)
  • Abstract (300 word max)
  • 2-3 sentence lay summary of your project.
  • Specific aims (1 page), research plan (3 page limit for publications support, small, and fellows grants; 5 page limit for large grants), and references (no page limit). (Download template: WORD)
  • Budget and justification (Download template: WORD / PDF)
  • NIH-formatted biosketches for PI and all co-Is (4 page limit per biosketch; please combine all biosketches into one PDF with the PI biosketch on top/listed first.)
  • Letters of support
    • Required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
    • Letters of support from collaborators, mentors and institution for all other applications are highly recommended.

Use the templates provided when you submit your final application. Once you have read all information below and have your application ready:

                   

Important information for 10/2/17 Large and Small Grant Submissions

Letter of Intent (LOI)

  • LOI’s are required for those submitting Large Grants (only) and are due September 1, 2017. The LOI should be a one-page signed letter which summarizes your ultimate full proposal.  Contents should include the name of your institution and a short description and aims of the project involved.  You should also include how your project fits CARRA’s guidelines and funding interests. The LOI is for informational purposes only, and approval is not needed to proceed with the full application.

Eligibility

  • The project PI for all grants must be a CARRA member in good standing:
    • Member is current on membership dues and membership information (location, contact information, and membership status) is up-to-date.
    • Member participates in at least one Research Committee (e.g. JDM, JIA, SVARD, etc.) of CARRA.
    • Member has attended at least one annual CARRA meeting over the last 3 year period.
  • An investigator may only receive one CARRA grant (large or small) per year (365 day period). 
  • PhD and Masters level researchers, nurses and research coordinators are eligible to submit proposals.
  • Priority will be given to new and/or early investigators.
  • All grants must be submitted by or have a pediatric rheumatologist named as a Co-I.
  • Fellows, residents, and CARRA Executive Committee members are not eligible.

Funding and Funding Period

  • Awards are total costs. Up to 8% F&A (indirect) costs are allowed, but costs must be incorporated into the project budget and not exceed the advertised award amount.
  • Publication, presentation, and travel costs should not be requested/included, unless the travel is an essential part of performing the research.
  • Salary support will be limited to a base-salary cap of $200,000 but can include payment of local fringe rates (on top of $200,000 salary cap).
  • Please review CARRA’s statement of direct and indirect support.
  • After funding decisions are determined, one large and two small grants will be selected by CARRA to be sponsored by funding received from AOII.
  • All awards are for one year, with funding to begin January 2, 2018.
  • Applicants will be notified of funding decisions no later than December 22, 2017.
  • If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 12 months.  Requests for NCEs will not be accepted prior to December 1, 2018. Recipient must submit a satisfactory plan for completion and an interim progress report between December 1-31, 2018. 

Reporting

  • Awardees must submit a progress report by December 31, 2018.
  • Awardees from the October, 2017 grant cycle who wish to submit grant applications for the October, 2018 deadline will be required to submit progress reports prior to October 1, 2018. Please use this template for progress reports.
  • Timely provision of progress reports is required for future eligibility for CARRA grants.
  • Awardees are expected to submit abstracts to CARRA and present their findings at the CARRA Annual Scientific Meeting.
    • 2018 abstracts are due January 15, 2018 and should include project/study overview.
    • 2019 abstracts to include project/study results.
    • CARRA will handle poster printing and costs.

Publications

  • Awardees are expected to submit a peer-reviewed abstract to a scientific meeting based on the funded project.
  • All awardees of CARRA funding must abide by the procedures outlined in the CARRA Publications Policy when presenting/publishing findings from their projects. This includes submitting all abstracts and manuscripts to the CARRA Publications Committee for approval prior to submission and acknowledging the support of CARRA and the Arthritis Foundation by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA.” Refer to the current Publications Policy for complete details.

CARRA Large Grant

LOIs due: September 1
Applications due: October 2

This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. New or early investigators are encouraged to apply and will be afforded special consideration.  A successful application may be for:

  • an all-inclusive clinical or translational research project; or
  • a pilot research project, that if successful, could lead to extramural funding.

Preference will be given to submissions which are collaborative and leverage current CARRA network resources or will further develop the CARRA network.

Details:

  • A maximum of 2 grants will be awarded per year.
  • The funding limit of each grant is $50,000 total costs.
  • Salary/Effort: Letters of support are required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $50,000. Indirects may not exceed 8%.
  • A given investigator can only receive one grant (large or small) per 365 day period.
  • Funds will be provided to the awardee through a contract between the PI’s institution and CARRA.
  • The project period is one year from the date of award.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • If requested, CARRA generally accepts up to $25K for salary support with a larger amount considered only under special circumstances with adequate justification.
  • After funding decisions are determined, one large grant will be selected by CARRA to be sponsored by funding received from AOII.

Instructions:

  • Submit a one-page LOI on institution letterhead by September 1 via the online grant submission system.  The LOI should be a one-page signed letter which summarizes your ultimate full proposal.  Contents should include the name of your institution and a short description and aims of the project involved.  You should also include how your project fits CARRA’s guidelines and funding interests. The LOI is for informational purposes only, and approval is not needed to proceed with the full application.
  • Use the template documents provided above and submit your completed CARRA Large Grant application by October 2 via the online grant submission system.

CARRA Small Grant

Applications due: March 1 & October 2
(Two rounds per year)

This opportunity is available to support projects in development.  New or early investigators are encouraged to apply and will be afforded special consideration.  The research project can be a pilot, continuation of ongoing research, or other projects that move forward clinical or translational research that furthers the CARRA mission. Preference will be given to research that is collaborative in nature, which leverage current CARRA network resources and/or will further develop the CARRA network.

Details:

  • There is no pre-specified number of grants available.
  • The funding limit of each grant is $25,000 (Requests for a lesser amount are highly encouraged).
  • Salary/Effort: Letters of support are required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $25,000. Indirects may not exceed 8%.
  • A given investigator can only receive one grant (large or small) per 365 day period.
  • Funds will be provided to the awardee through one of 2 mechanisms:
  1. By invoice for payment for materials or services in support of the funded project; or
  2. as an unrestricted grant provided as a lump sum to a sundry account used by the PI according to the project budget.
  • The project period is one year from the date of award.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting.  
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • This funding mechanism is not intended for projects that are already eligible/appropriate for extramural funding.
  • After funding decisions are determined, two small grants will be selected by CARRA to be sponsored by funding received from AOII.

Instructions:

  • Use the template documents provided above and submit your completed CARRA Small Grant application by October 2, 2017 via the online grant submission system.
  • The next deadline for CARRA Small Grant Applications will be March 1, 2018.

CARRA Fellow Small Grant (Applications due March 1)

This grant mechanism is exclusively available for fellows entering their third year who wish to perform a CARRA-related research project. The project must not be necessary to meet the ABP requirement for scholarly work product, but it may be supplemental.

  • Non-pediatric rheumatology fellows are not eligible.
  • Fellows must have a mentor listed on their application. Mentor does not need to be a pediatric rheumatologist.

Instructions

  • Use the template documents provided above and submit your completed CARRA Fellow Small Grant application by March 1, 2018 via the online grant submission system.

CARRA Publication Support Grant

This funding opportunity is available to researchers to support efforts required to bring existing data from collaborative research projects to publication.  New or early investigators are encouraged to apply and will be afforded special consideration.

Details:

  • Up to 5 grants will be awarded in 2017.
  • The funding limit of each grant is $10,000.
  • A given investigator can only apply for one Publication Support grant per year.
  • A given investigator may also be a recipient of a CARRA large or small grant.
  • Preference will be given to research that is collaborative in nature and has used CARRA infrastructure.
  • Grants will be considered on a rolling basis until 5 are awarded: simply complete and submit your request.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting

Instructions:

  • Use the template documents provided above and submit your completed Publication Support application via the online grant submission system.
  • Applications will be reviewed by the CARRA Executive Committee.
  • Notification will occur within 4 weeks of application submission.

Publication Support Grant submission form


CARRA Research Coordinator Advisory Committee (RCAC) Scholarships for Professional Certification and Continuing Education

CARRA’s RCAC is offering 13 scholarships of up to $200 each to help supplement costs of completing or continuing SOCRA or ACRP certification for CARRA research coordinators.  Applications are reviewed on a rolling basis and each applicant can only receive funding once per fiscal year.

Applicants must be current CARRA Research Associate (coordinator) members. Applications are submitted at:  https://wiki.carragroup.org/display/RAAC/Funding+opportunities+for+CARRA+Coordinators.

If you have any questions, you can email Jennifer Woo, RCAC Chair, at [email protected].


CARRA Registry Internship
Applications were due March 24, 2017. Established through funds at the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Inc., the CARRA Registry Internship will require 25% effort for one year. Read more…


The Utrecht Summer School Program Sponsorship Program

Utrecht Travel Sponsorship Awardees
CARRA is pleased to announce that Maya Breitman (MetroHealth) and Theresa Wampler Muskardin (Mayo Clinic) were recently chosen as the recipients for CARRA sponsorship to Utrecht’s Summer School Program. They will participate in 5 day course in July in Utrecht entitled “Why Translational Medicine Fails – And What to do About it.”

2nd Round Recipients of the CARRA Small Grant have been announced:

Our second round of Small Grants were evaluated and scored through a peer review process. Click here to view the complete list of recipients along with their project titles.

Recipients of the CARRA Large Grant have been announced:

Andrea KnightAndrea Knight
$50,000 for her submission entitled “The Impact of Mental Health Disorders on Medication Adherence & Health Care Utilization in Youth with Lupus.”
Betsy Mellins  Vivian E. Saper
Betsy Mellins & Vivian Saper
$50,000 for their submission entitled “Clinical and translational investigation of parenchymal lung disease in sJIA: A planning grant.”


Recipients of the CARRA Publications Support Grants have been announced:

Emily von SchevenEmily von Scheven
For her submission entitled “A Pilot Study of Consensus Treatment Plans (CTPs) for Induction Therapy in Childhood Proliferative Lupus Nephritis cLN)”
Sarah Ringold
Sarah Ringold
For her submission entitled “Sequence of Medication Use in JIA”
Suzanne Li
Suzanne Li
For her 3 submissions entitled “Process paper on steps involved in working towards conducting comparative effectiveness studies in a rare disease,” “Initial results of the jLS CTP pilot study,” and “Clinical assessment tools for jLS.”

Additional Funding Opportunities:

The Cure JM Foundation (Cure JM) announces its Request for Proposals for 2017 for advancing research to improve medical treatment, patient care, and work toward a cure for Juvenile Myositis. Grants are made in collaboration with CARRA. In 2017, Cure JM has committed to fund 2-4 new research grants up to $75K/year for up to 2 years with preference for individuals who have at least 25% protected research time from their institution. Click here for more information and links to online applications.

Pfizer provides grants for autoimmune and inflammatory disease research. Applications can be on basic research in the etiology of autoimmune and inflammatory diseases or clinical research. This program is available only to junior and senior investigators based in the United States. Awards can be up to a maximum of $150,000 each. Research projects are expected to be completed within two years. Larger grants may be considered depending on scope and merit of the proposal. Review the process and opportunities here.

NIAMS Research Funding

NIAID Research Funding

ACR REF Awards and Grants